New cancer drugs are making headlines, Iressa, Velcade, Avastin
June 2003
New cancer drugs are making headlines, Iressa, Velcade, Avastin.
They each have an important new mechanism of action.
Iressa (gefitinib) is a new ORAL drug for lung cancer. It's an "epidermal growth factor inhibitor"...just for patients whose cancer progresses despite standard chemotherapy.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote